Cargando…
Identification of Dietary Bioflavonoids as Potential Inhibitors against KRAS G12D Mutant—Novel Insights from Computer-Aided Drug Discovery
The KRAS G12D mutation is very frequent in many cancers, such as pancreatic, colon and lung, and has remained undruggable for the past three decades, due to its smooth surface and lack of suitable pockets. Recent small pieces of evidence suggest that targeting the switch I/II of KRAS G12D mutant cou...
Autores principales: | Ramalingam, Prasanna Srinivasan, Balakrishnan, Purushothaman, Rajendran, Senthilnathan, Jothi, Arunachalam, Ramalingam, Rajasekaran, Arumugam, Sivakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047893/ https://www.ncbi.nlm.nih.gov/pubmed/36975507 http://dx.doi.org/10.3390/cimb45030137 |
Ejemplares similares
-
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
por: Ramalingam, Prasanna Srinivasan, et al.
Publicado: (2023) -
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2019) -
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2020) -
Bioflavonoids and the Capillary
por: Goodyer, Allan V. N.
Publicado: (1955) -
Cryopreservation of bioflavonoid-rich plant sources and bioflavonoid-microcapsules: emerging technologies for preserving bioactivity and enhancing nutraceutical applications
por: Xiang, Jia, et al.
Publicado: (2023)